The effects of early insulin treatment combined with thrombolysis in rat embolic stroke.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The effects of early insulin treatment combined with thrombolysis in rat embolic stroke. / Meden, Per; Andersen, Martin; Overgaard, Karsten; Rasmussen, Rune Skovgaard; Boysen, Gudrun.
I: Neurological Research, Bind 24, Nr. 4, 2002, s. 399-404.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The effects of early insulin treatment combined with thrombolysis in rat embolic stroke.
AU - Meden, Per
AU - Andersen, Martin
AU - Overgaard, Karsten
AU - Rasmussen, Rune Skovgaard
AU - Boysen, Gudrun
N1 - Keywords: Animals; Blood Glucose; Carotid Arteries; Cerebral Infarction; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hypoglycemic Agents; Insulin; Male; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Time Factors; Tissue Plasminogen Activator
PY - 2002
Y1 - 2002
N2 - The therapeutic effect of insulin alone or insulin combined with 30 min delayed thrombolytic therapy was investigated in rats embolized in the right hemisphere with a fibrin clot made from autologous blood. Animals were killed seven days after embolization and the infarct volumes were measured in % of the affected hemisphere. Mortality was calculated as the number of animals dying spontaneously before the scheduled euthanasia. The median infarct volume in control animals (n = 12) was 24%. Insulin (3 IU kg(-1)) was given subcutaneously 15 min, 3 h, and 24 h after embolization (n = 12) and reduced median infarct volume to 11%. Human recombinant tissue plasminogen activator, 8 mg kg(-1), was infused intravenously during 45 min starting 30 min after embolization (n = 14), and the median infarct volume was 18% in this group. When the two treatments were combined, the median infarct volume was reduced to 11% (n = 14). The infarct volumes in the treatment groups were not significantly different from controls (p = 0.62, Kruskal Wallis test). Mortality rates increased from 0% among controls to 47% (p = 0.01) in the insulin alone and 38% (p = 0.02) in the combination therapy group. In conclusion, insulin treatment aiming at blood glucose levels around 2-4 mmol l(-1) was detrimental to clinical outcome causing significantly increased mortality.
AB - The therapeutic effect of insulin alone or insulin combined with 30 min delayed thrombolytic therapy was investigated in rats embolized in the right hemisphere with a fibrin clot made from autologous blood. Animals were killed seven days after embolization and the infarct volumes were measured in % of the affected hemisphere. Mortality was calculated as the number of animals dying spontaneously before the scheduled euthanasia. The median infarct volume in control animals (n = 12) was 24%. Insulin (3 IU kg(-1)) was given subcutaneously 15 min, 3 h, and 24 h after embolization (n = 12) and reduced median infarct volume to 11%. Human recombinant tissue plasminogen activator, 8 mg kg(-1), was infused intravenously during 45 min starting 30 min after embolization (n = 14), and the median infarct volume was 18% in this group. When the two treatments were combined, the median infarct volume was reduced to 11% (n = 14). The infarct volumes in the treatment groups were not significantly different from controls (p = 0.62, Kruskal Wallis test). Mortality rates increased from 0% among controls to 47% (p = 0.01) in the insulin alone and 38% (p = 0.02) in the combination therapy group. In conclusion, insulin treatment aiming at blood glucose levels around 2-4 mmol l(-1) was detrimental to clinical outcome causing significantly increased mortality.
M3 - Journal article
C2 - 12069290
VL - 24
SP - 399
EP - 404
JO - Neurological Research
JF - Neurological Research
SN - 0161-6412
IS - 4
ER -
ID: 8441799